Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Stock
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
17.7M
-
Shares change
-
-898K
-
Total reported value, excl. options
-
$41.5M
-
Value change
-
-$4.94M
-
Number of buys
-
16
-
Number of sells
-
-24
-
Price
-
$2.35
Significant Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q4 2018
62 filings reported holding CDTX - CIDARA THERAPEUTICS INC COM NEW - Stock as of Q4 2018.
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.7M shares
.
Largest 10 shareholders include BVF INC/IL (2.9M shares), BB BIOTECH AG (2.3M shares), Omega Fund Management, LLC (1.51M shares), INTERWEST VENTURE MANAGEMENT CO (1.36M shares), FRAZIER MANAGEMENT LLC (1.31M shares), Opaleye Management Inc. (1.2M shares), Aisling Capital LLC (1.02M shares), Vanguard Group Inc (866K shares), Alethea Capital Management, LLC (482K shares), and Monashee Investment Management LLC (481K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.